Sano Takanori, Kobayashi Kazuto, Ichikawa Tomonori, Hakozaki Koichi, Tanemura Hiroshi, Ishigaki Tomoki, Miya Fumitaka
Department of Neurosurgery, Ise Red Cross Hospital, Ise, Mie, Japan.
Department of Neurology, Ise Red Cross Hospital, Ise, Mie, Japan.
J Neuroendovasc Ther. 2020;14(4):133-140. doi: 10.5797/jnet.oa.2019-0048. Epub 2020 Mar 2.
We investigated in-hospital stroke (IHS) treated by mechanical thrombectomy in comparison with out-of-hospital stroke (OHS) to clarify the points of concern in IHS at our institution.
Between September 2015 and June 2018, 19 patients with IHS who underwent mechanical thrombectomy (IHS group) were enrolled, and compared with 154 patients with OHS (OHS group) regarding patient characteristics, technical results, and outcome. In this study, we set the detection time in the IHS group as patient arrival time, termed "Door" in the OHS group.
Cardiology and gastroenterology were the two main admitting departments, including four (21%) patients of IHS group. In all, 15 (79%) patients had atrial fibrillation; however, less than one-third of them was taking anticoagulant drugs at onset. There were only two cases of direct consultation to the stroke specialists, although IHS onset was mainly recognized by nurses. The median age in the IHS group was 81 (interquartile range (IQR), 76-86.5) versus 80 in the OHS group (IQR, 73-85; p = 0.43), and the median initial National Institutes of Health Stroke Scale score was 21 (IQR, 16-23) versus 21 (IQR, 14-26; p = 0.92), respectively. Sex, Alberta Stroke Program Early CT Score, etiology, and occlusion site did not differ between groups. The rate of use of intravenous tissue plasminogen activator (IV-tPA) was 26% in the IHS group versus 49% in the OHS group (p = 0.065). The median time of detection to imaging, detection to needle for IV-tPA, and detection to puncture were 32, 69, and 87 minutes, respectively, in the IHS group, being significantly longer than those in the OHS group (11, 30, and 50 minutes; p <0.01, p <0.01, and p <0.01, respectively). The median time of puncture to reperfusion was 39 minutes, being significantly shorter than that in the OHS group (82 minutes; p <0.01). Successful reperfusion defined as thrombolysis in cerebral infarction (TICI) 2b-3 was obtained in 94.7% of the IHS group versus 83.1% of the OHS group (p = 0.19). A favorable outcome (modified Rankin Scale score 0-2) at 90 days was achieved by 36.8% (IHS) versus 35.1% (OHS) of patients (p = 0.88). The rate of symptomatic procedural complications was 0% (IHS) versus 7.1% (OHS; p = 0.23). The rate of death at 90 days was 15.8% (IHS) versus 12.3% (OHS; p = 0.67).
The times of detection to imaging and of detection to puncture in the IHS group were longer than those in the OHS group; however, patients in the IHS group had shorter reperfusion. The outcome of the IHS group did not differ from that of OHS group. Our study suggests that the time course of treatment should be improved and rapid stroke pathways involved in consultation with the stroke specialists for IHS should be organized.
我们对机械取栓治疗的院内卒中(IHS)与院外卒中(OHS)进行了研究,以明确我院IHS治疗中需要关注的要点。
2015年9月至2018年6月,纳入19例行机械取栓的IHS患者(IHS组),并与154例OHS患者(OHS组)在患者特征、技术结果和预后方面进行比较。在本研究中,我们将IHS组的检测时间设定为患者到达时间,在OHS组中称为“门到”时间。
心脏病科和消化内科是两个主要收治科室,IHS组有4例(21%)患者。总共有15例(79%)患者患有房颤;然而,其中不到三分之一的患者在发病时正在服用抗凝药物。尽管IHS发病主要由护士发现,但仅有2例直接咨询了卒中专科医生。IHS组的中位年龄为81岁(四分位间距(IQR),76 - 86.5),OHS组为80岁(IQR,73 - 85;p = 0.43),IHS组美国国立卫生研究院卒中量表初始中位评分分别为21分(IQR,16 - 23)和21分(IQR,14 - 26;p = 0.92)。两组在性别、阿尔伯塔卒中项目早期CT评分、病因和闭塞部位方面无差异。IHS组静脉注射组织型纤溶酶原激活剂(IV - tPA)的使用率为26%,OHS组为49%(p = 0.065)。IHS组检测到影像学检查、检测到静脉注射IV - tPA的穿刺针以及检测到穿刺的中位时间分别为32分钟、69分钟和87分钟,显著长于OHS组(11分钟、30分钟和50分钟;p <0.01、p <0.01和p <0.01)。穿刺到再灌注的中位时间为39分钟,显著短于OHS组(82分钟;p <0.01)。IHS组94.7%的患者实现了定义为脑梗死溶栓(TICI)2b - 3级的成功再灌注,OHS组为83.1%(p = 0.19)。90天时90天良好预后(改良Rankin量表评分0 - 2)的患者比例在IHS组为36.8%,OHS组为35.1%(p = 0.88)。有症状的手术并发症发生率在IHS组为0%,OHS组为7.1%(p = 0.23)。90天时的死亡率在IHS组为15.8%,OHS组为12.3%(p = 0.67)。
IHS组检测到影像学检查和检测到穿刺的时间长于OHS组;然而,IHS组患者的再灌注时间较短。IHS组的预后与OHS组无差异。我们的研究表明,应改善治疗的时间进程,并应建立涉及IHS患者咨询卒中专科医生的快速卒中流程。